Johnson & Johnson Investor Presentation — April 2018

Document content

Vice President, Investor Relations4

Financial Results Review and Guidance

Q&ASales Performance and HighlightsCautions Concerning Forward -looking Statements

This presentation contains “forward -looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regar ding, among other things: future

operating and financial performance, product development, market position and business strategy. The viewer is cautioned not to rely on these forward -looking

statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate o r known or unknown risks or

uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. R isks and uncertainties include, but are not

limited to: economic factors, such as interest rate and currency exchange rate fluctuations; competition, including technolog ical advances, new products and patents

attained by competitors; challenges inherent in new product research and development, including uncertainty of clinical succe ss and obtaining regulatory approvals;

uncertainty of commercial success for new and existing products; challenges to patents; the impact of patent expirations; the ability of the company to successfully

execute strategic plans, including restructuring plans; the impact of business combinations and divestitures; manufacturing d ifficulties or delays, internally or within the

supply chain; product efficacy or safety concerns resulting in product recalls or regulatory action; significant adverse liti gation or government action, including related to

product liability claims; changes to applicable laws, regulations and government policies, including tax laws and global heal th care reforms; trends toward health care